BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 4101489)

  • 1. The ninth component of guinea-pig complement. Isolation and identification as an alpha 2-globulin.
    Tamura N; Shimada A
    Immunology; 1971 Mar; 20(3):415-25. PubMed ID: 4101489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unknown guinea-pig immunoglobulin with strong antibody activity to egg albumin.
    van Es L; Kwant-den Harink H; Pondman KW
    Immunology; 1973 Jun; 24(6):1087-97. PubMed ID: 4123962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the third component (C'3) of guinea pig complement. I. Purification and characterization.
    Yonematsu K; Inoue K
    Biken J; 1968 Sep; 11(3):169-80. PubMed ID: 4976235
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies produced after immunization with substituted meta-dinitrobenzenes. Production of gamma 1 and gamma 2 classes of antibody including complement-dependent antibodies.
    Godfrey HP; Baer H
    J Immunol; 1971 May; 106(5):1201-12. PubMed ID: 4102399
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteins adhering to Escherichia coli after exposure to guinea-pig serum.
    Beernink KD; Steward JP
    Immunology; 1967 Feb; 12(2):207-18. PubMed ID: 4960111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of the monospecific antiserum directed to the ninth component of human complement (C9).
    Kawachi-Takahashi S; Tanaka K; Takahashi M
    Jpn J Exp Med; 1974 Jun; 44(3):283-90. PubMed ID: 4215913
    [No Abstract]   [Full Text] [Related]  

  • 7. A simple method for the isolation of the subcomponents of the first component of complement by affinity chromatography.
    Assimeh SN; Bing DH; Painter RH
    J Immunol; 1974 Jul; 113(1):225-34. PubMed ID: 4857625
    [No Abstract]   [Full Text] [Related]  

  • 8. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE; Spitzer RE
    J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
    [No Abstract]   [Full Text] [Related]  

  • 9. Separation of C'4 from C'1 inactivator and purification of both substances.
    Inai S; Hiramatsu S; Nagaki K
    Biken J; 1967 Sep; 10(3):155-74. PubMed ID: 4170106
    [No Abstract]   [Full Text] [Related]  

  • 10. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
    Ballow M; Cochrane CG
    J Immunol; 1969 Nov; 103(5):944-52. PubMed ID: 4981797
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation of antisera monospecifically reactive with the fourth component of guinea pig complement.
    Burkholder PM
    Int Arch Allergy Appl Immunol; 1969; 35(6):552-63. PubMed ID: 4977621
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of serum C9 level by immunodiffusion. Elevation in patients with infectious or allergic skin diseases.
    Kawachi-Takahashi S; Tanaka K; Takahashi M; Kawashima T; Shimada K
    Int Arch Allergy Appl Immunol; 1975; 48(2):161-70. PubMed ID: 46851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin.
    Snyderman R; Shin HS; Phillips JK; Gewurz H; Mergenhagen SE
    J Immunol; 1969 Sep; 103(3):413-22. PubMed ID: 5805427
    [No Abstract]   [Full Text] [Related]  

  • 14. A method for preparing monospecific antisera to Cl esterase (Cls): microheterogeneity of purified Cls.
    Nagaki K; Stroud RM
    J Immunol; 1970 Jul; 105(1):162-9. PubMed ID: 4988888
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine rich beta-glycoprotein (GBG or factor B).
    Brade V; Cook CT; Shin HS; Mayer MM
    J Immunol; 1972 Dec; 109(6):1174-81. PubMed ID: 4628703
    [No Abstract]   [Full Text] [Related]  

  • 16. Electron microscopy of the third component of guinea pig complement.
    Suzuki I; Okada H; Takahashi S; Takahashi M; Nishioka K
    Jpn J Exp Med; 1972 Jun; 42(3):309-13. PubMed ID: 4538157
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the immunogenicity of antigen-antibody precipitates. 1. The suppressive effect of anti-L and anti-H chain antibodies on the immunogenicity of human gammaG globulin.
    Henney CS; Ishizaka K
    J Immunol; 1968 Nov; 101(5):896-904. PubMed ID: 4972233
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
    Kempf RA; Gigli I; Austen KF
    J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
    [No Abstract]   [Full Text] [Related]  

  • 20. Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.
    Tamura N; Nelson RA
    J Immunol; 1967 Sep; 99(3):582-9. PubMed ID: 6051385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.